Therapeutic Areas Doctors & Pharmacists

• With the Genuair^® products, consisting of Bretaris^® Genuair^® (aclidinium bromide) and Brimica^® Genuair^® (aclidinium bromide/formoterol fumarate), we offer a continuous therapy for COPD patients who benefit from a 2x daily inhalation.

AT-WEB-09-05-2023

Allergology

Abnormal and specific reactions of the immune system to allergens are becoming more common, creating an increasing need for drug treatment of allergies. Allergic rhinitis (AR), a symptomatic disease of the nose triggered by IgE-mediated inflammation of the nasal mucosa after allergen exposure, is a common comorbidity of asthma and contributes to its development and severity, can also be well treated.¹

A. Menarini Pharma GmbH offers suitable therapies for different patient profiles:

• With the anti-allergic Olisir^® (Bilastin), a fast-acting and well-tolerated preparation is available, which provides allergy patients with good symptom relief² and is available over the counter³.
• The new nasal spray Ryaltris™ (mometasone furoate/ olopatadine) for allergic rhinitis not only effectively controls the classic symptoms of allergic rhinitis, such as sneezing, nasal itching, nasal congestion and rhinorrhea ^4-6 , but also improves patients' quality of life during short- ^4,5 and long-term ⁶ use.
  
  
  

References: 1 World Allergy Organization (2005). In-depth review of allergic rhinitis. [online] (last updated October 2020). Available at: https://www.worldallergy.org/education-and-programs/education/allergic-disease-resource-center/professionals/in-depth-review-of-allergic-rhinitis [accessed 31.05.2023]; 2 Horak F et al. Inflamm Res. 2010 May;59(5):391–8; 3 Warenverzeichnis; 4 Gross GN, Berman G, Amar NJ, et al. Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2019;122(6):630-638.e3; 5 Hampel FC, Pedinoff AJ, Jacobs RL, et al. Olopatadine-mometasone combination nasal spray: evaluation of efficacy and safety in patients with seasonal allergic rhinitis. Allergy Asthma Proc 2019;40(4):261-272.; 6 Segall N, Prenner B, Lumry W, et al. Long-term safety and efficacy of olopatadine-mometasone combination nasal spray in patients with perennial allergic rhinitis. Allergy Asthma Proc 2019;40(5):301-31




AT-WEB-08-05-2023